Clinical features and antimicrobial resistance of invasive non-typhoid Salmonella infection in children at Xiamen.
10.3760/cma.j.cn112140-20230227-00135
- Author:
Cai Hong WANG
1
;
Mei Lian HUANG
2
;
Zhi Qiang ZHUO
1
;
Zi Xuan WANG
3
;
Lei CHEN
2
;
Yi Qing SONG
1
;
Hui YU
3
Author Information
1. Department of Infectious Diseases, Xiamen Hospital (Xiamen Children's Hospital), Children's Hospital of Fudan University, Xiamen 361006, China.
2. Department of Clinical Medical Labortaory,Xiamen Hospital (Xiamen Children's Hospital), Children's Hospital of Fudan University, Xiamen 361006, China.
3. Department of Infectious Diseases, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai 201102, China.
- Publication Type:Journal Article
- MeSH:
Infant;
Male;
Female;
Child;
Humans;
Child, Preschool;
Anti-Bacterial Agents/therapeutic use*;
Ceftriaxone/therapeutic use*;
Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use*;
Ceftazidime/therapeutic use*;
Retrospective Studies;
C-Reactive Protein;
Drug Resistance, Bacterial;
Salmonella Infections/microbiology*;
Ampicillin/therapeutic use*;
Salmonella;
Diarrhea/drug therapy*;
Bacteremia;
Abdominal Pain;
Microbial Sensitivity Tests
- From:
Chinese Journal of Pediatrics
2023;61(8):685-689
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the clinical characteristics, serogroups and antimicrobial resistance of invasive non-typhoid Salmonella infection in children at Xiamen. Methods: Retrospective cohort study. The clinical manifestations, treatment, prognosis, serogroups and antimicrobial resistance of 29 hospitalized children with invasive non-typhoid Salmonella infection confirmed by blood, cerebrospinal fluid, bone marrow and other sterile body fluids or deep pus culture at the Department of Infectious Diseases, the Department of Orthopedics and the Department of General Surgery in Xiamen Children's Hospital from January 2016 to December 2021 were analyzed. According to the clinical diagnosis criteria, the patients were divided into sepsis group and non-sepsis group (bacteremia and local suppurative infection). The inflammatory markers, serogroups distribution and drug resistance were compared between the two groups. Comparison between groups using Mann-Whitney U test and χ2 test. Results: Among the 29 cases, there were 17 males and 12 females, with an onset age of 14 (9, 25) months, and 10 cases (34%) of patients were younger than 1 year old, 15 cases (52%) under 1 to 3 years old, and 4 cases (14%) greater than or equal 3 years old. The onset time of 25 cases (86%) was from April to September. The diseases included 19 cases (66%) septicemia (2 of which were combined with suppurative meningitis), 10 cases (34%) non-sepsis group, including 7 cases bacteremia and 3 cases local suppurative infection (2 cases of osteomyelitis, 1 case of appendicitis with peritonitis). The clinical manifestations were fever in 29 cases (100%), diarrhea and abdominal pain in 18 cases (62%), cough and runny nose in 10 cases (34%). Eighteen cases (62%) were cured and 11 cases (38%) were improved by effective antibiotics treatment. C-reactive protein in sepsis group was significantly higher than that in non-sepsis group (25.2 (16.1, 56.4) vs. 3.4 (0.5, 7.5) mg/L, Z=-3.81, P<0.001).The serogroups of C, B and E were the most prevalent among non-typhoid Salmonella isolates, accounting for 10 cases (34%), 9 cases (31%) and 7 cases (24%) respectively. Antibacterial drug sensitivity test showed that the sensitivity rates of imipenem, ertapenem and piperaciratazobactam were all 100% (31/31), those of ceftazidime, ceftriaxone, and cefepime were 94% (29/31), 94% (29/31) and 97% (30/31) respectively. The drug resistance rates of ampicillin, ampicillin-sulbactam and trimethoprim-sulfamethoxazole were 51% (16/31), 48% (15/31) and 48% (15/31) respectively, those of cefazolin, cefotetan, tobramycin, gentamicin and amikacinwere all 100% (31/31). There were no significant differences in the drug resistance rates of ceftazidime, ceftriaxone, aztreonam, ampicillin-sulbactam, ampicillin, trimethoprim-sulfamethoxazole and ciprofloxacin between the sepsis group and the non-sepsis group (χ2=0.31,0.31,0.00,0.02,0.02,0.02,0.26, all P>0.05). Conclusions: Invasive non-typhoid Salmonella infection in children at Xiamen mainly occurred in infants younger than 3 years old.The main clinical manifestations are fever, abdominal pain and diarrhea. C-reactive protein can be served as the laboratory indicators for indicating sepsis. The third generation of cephalosporins is recommended as the first choice for treatment.
